AN2 Therapeutics | Investor Presentation Deck | 36 slides · page 27 of 36
The chart demonstrates superior efficacy of the lead compound over existing treatments (Benznidazole and E1224) in a model that mirrors human clinical outcomes.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
chart 1/1 list 4/4 source-note 1/1 title 1/1
Components 7
line bullet bullet bullet bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.